Ir >>   
Uds: 0
Importe: 0,00
Tengo un usuario, deseo validarme - regístrate
  Buscar/Pesquisa        Búsqueda avanzada  
Herramienta de traducción gratuita de páginas web
Inicio/Iniciação
 > Libros de Medicina  > Psiquiatría  > Psiquiatría General  - Llámanos (+34) 913788918 ¡Gasto de envío gratis para pedidos superiores a 50€ (sin iva) en Península!
Diagnostic Issues in Substance Use Disorders. Refining the Research Agenda for DSM-V
Diagnostic Issues in Substance Use Disorders. Refining the Research Agenda for DSM-V
Edición/Edição: 1
Autores: Darrel A. Regier; Paul J. Sirovatka; Marc A. Schuckit; John B. Saunders
Editorial:
ISBN: 9780890422991
Formato: Rústica/Paperback
Nº volumenes: 1 Páginas: 352
Año publicación/Ano de publicação: 2007
Disponibilidad/Disponibilidade: 15 días
Precio/Preço : 63,10 € 59,94 € (62,34€ iva incluído)
 (Sea el primero en opinar ) ¿Vas a pedir más de 5 productos? Escríbenos, te enviaremos presupuesto ajustado, envíanos mail

Cómpralos juntos y ahorra
Diagnostic Issues in Substance Use Disorders. Refining the Research Agenda for DSM-V Massachusetts General Hospital. Tratado de Psiquiatría Clínica + ExpertConsult 2ª Ed.
· Diagnostic Issues in Substance Use Disorders. Refining the Research Agenda for DSM-V (Darrel A. Regier; Paul J. Sirovatka; Marc A. Schuckit; John B. Saunders)
· Massachusetts General Hospital. Tratado de Psiquiatría Clínica + ExpertConsult 2ª Ed. (Theodore A. Stern | Maurizio Fava | Timothy E. Wilens | Jerrold F. Rosenbaum)
231,37 € 219,80 €
Descripción/Descrição
Inviting the help of colleagues worldwide, the concise Diagnostic Issues in Substance Use Disorders is part of the new series Advancing the Research Agenda for DSM-V. Its 19 chapters by an international group of experts are designed to stimulate questions that will help guide research related to the development of the next editions of the Diagnostic and Statistical Manual of Mental Disorders (DSM-V) and the International Classification of Diseases (ICD-11), with the goal of ensuring that the major substance use diagnoses represent the same condition in both references. They cover 10 major issues in three main sections:




Overarching issues relevant for the development of international diagnostic systems—statistical modeling techniques and whether DSM-V should use categorical and/or dimensional diagnostic approaches; methods review, emphasizing new hybrid techniques for developing and testing diagnostic concepts; the need for separate clinical and research-oriented diagnostic criteria, incorporating both categorical and dimensional attributes; neurobiological changes characterizing substance dependence; the importance of cultural attributes in developing definitions of substance use disorders; and the history of the development of diagnostic systems and how to optimize the "crosswalk" between DSM and ICD.

Research questions more specific to the substance use disorders section of DSM—comorbidity between substance use disorders and other psychiatric conditions, the relatively unique clinical course of substance-induced mental disorders and appropriate treatment approaches; the precision of the criteria and threshold for a diagnosis and how to improve them; the subtypes of substance use disorder, including how they have been derived and the extent to which they relate to neurobiological processes; the seemingly high prevalence of alcohol dependence in young people; suggested research questions to evaluate the application of diagnostic criteria to adolescents; and the specific psychoactive substances cannabis and nicotine.

Whether substance use disorders should be included in a broader section termed “addictive disorders”—impulse-control disorders (especially pathological gambling and the advantages and disadvantages of adding it to the current substance use disorders section), identifying research opportunities regarding their assessment and neurocognitive and physiological bases, discussing the specifics of the research agenda and how it might be implemented, and presenting questions generated by the research agenda developmental process.
This informative compendium distills the findings of a wealth of recent research and concludes with recommendations for exploiting research opportunities that promise to inform decisions regarding DSM-V and other classification systems. As such, it will prove invaluable for clinicians and researchers everywhere.

Contents

Contributors. Disclosure statement. Foreword. Introduction: development of a research agenda for substance use disorders diagnosis in DSM-V. Should substance use disorders be considered categorical or dimensional? Should there be both categorical and dimensional criteria for the substance use disorders in DSM-V? Neurobiology of addiction: a neuroadaptational view relevant for diagnosis. Cultural and societal influences on substance use diagnoses and criteria. Cultural issues and psychiatric diagnosis: providing a general background for considering substance use diagnoses. Substance dependence and nondependence in DSM and the ICD: can an identical conceptualization be achieved? Substance use disorders: DSM-IV and ICD-10. Comorbidity of substance use disorders with psychiatric conditions. Comorbidity of substance use with depression and other mental disorders: from DSM-IV to DSM-V. Are there empirically supported and clinically useful subtypes of alcohol dependence? Subtypes of substance dependence and abuse: implications for diagnostic classification and empirical research. Diagnosis of alcohol dependence in epidemiological surveys: an epidemic of youthful alcohol dependence or a case of measurement error? Adolescents and substance-related disorders: research agenda to guide decisions about DSM-V. Are specific dependence criteria necessary for different substances: how can research on cannabis inform this issue? Should criteria for drug dependence differ across drugs? Should addictive disorders include non-substance-related conditions? Should the scope of addictive behaviors be broadened to include pathological gambling? Characteristics of nosologically informative data sets that address key diagnostic issues facing the DSM-V and ICD-11 substance use disorders workgroups. Empirical basis of substance use disorders diagnosis: research recommendations for DSM-V.
Lo más vendido este mes/Os mais vendidos este mês
DSM-5 Manual diagnóstico y estadístico de los trastornos mentales
Panamericana, 2014
American Psyqhiatric Association | American Psychiatric Association
105,00 €
Tratado de Psiquiatría legal y forense + cd
La Ley, 2011
José Manuel Maza Martín | Juan José Carrasco Gómez
124,69 €
Stahl: autoevaluación en psiquiatría
Aula Médica, 2013
Stahl, S. | S. Stahl | Stephen M. Stahl | Stephen Stahl
39,90 €
Stahl: Psicofarmacología Esencial basada en la Evidencia
Aula Médica, 2013
Stephen Stahl | Bernard Lerer | Dan J. Stein
50,40 €
Kaplan & Sadock. Sinopsis de psiquiatri­a, 11e
LWW España, 2015
Virginia A. Sadock | Virginia A. Sadock MD | Benjamin J. Sadock MD | Benjamin J. Sadock
140,00 €
Suscripciones
Si desea suscribirse a nuestros boletines gratuitos por favor regístrese como usuario.
Atención clientes
Para realizar sus pedidos o consultas relacionadas con productos llame al:
(+34)91 378 89 18





 

Acerca de los certificados SSL
Nosotros subscribimos Los Principios del código HONcode de la Fundación Salud en la Red Nosotros subscribimos los Principios del código HONcode. Compruébelo aquí.